Billerica, MA 5/19/10—Bruker has completed the acquisition of Varian’s ICP-MS, laboratory GC and triple quadrupole–GC instrument product lines (see IBO 3/15/10), which make up the new Chemical Analysis Division (CAD), part of the Bruker Daltonics MS business (see IBO 4/15/10). More than 250 former Varian staff have joined Bruker as a result of the acquisition. “While the three new product lines form the core offerings of our new Chemical Analysis Division, we plan to add additional products for applied and industrial markets over time,” commented Dr. Frank Laukien, president and CEO of Bruker. In the remainder of the second quarter, Bruker expects CAD to contribute about $2 million in revenue and to show an operating loss of $1.5–$2.5 million, excluding one-time charges. Bruker’s goal over the next few years is to return the acquired product lines to historical financial performance levels, with expected annual revenue of $80–$100 million and operating margins of greater than 10%.